Navigation Links
Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
Date:1/24/2011

ting and financial planning.  These non-GAAP financial measures are in addition to, not a substitute for, or superior to, measures of financial performance prepared in conformity with GAAP. Further, our reconciliations of GAAP to "adjusted" operating results, which are included on the attached tables, are presented in the format of condensed consolidated statements of income solely to facilitate a reader's understanding of the impact of the various adjustments to our GAAP operating results, individually and in the aggregate, and are not intended to place any undue prominence on our adjusted operating results.

Forward-Looking StatementsThis news release contains forward-looking statements that involve significant risks and uncertainties, including those discussed below and others that can be found in our Form 10-K for the year ended Dec. 31, 2009, and in our periodic reports on Form 10-Q and Form 8-K.  Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements contained in this document as a result of new information, future events or otherwise.  

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  The Company’s results may be affected by our ability to successfully market both new and existing products domestically and internationally, clinical and regulatory developments (domestic or foreign) involving current and future products, sales growth of recently launched products, competition from other products (domestic or foreign) and difficulties or delays in manufacturing our products.  In addition, sales of our products are affected by reimbursement policies imposed by third-party payors, including governments, private insurance plans and managed care providers and may be affected by regulatory, clinical and guideline developments and domestic and international trends t
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. PLC Systems Reports Fourth Quarter 2007 Results
5. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
6. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
7. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
8. Novavax Reports Fourth Quarter and 2007 Year-End Financial Results
9. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
10. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
11. Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... N.C. , July 25, 2014  In today,s ... is costly and challenging - as is managing a ... Is it possible - or even preferable ... If so, where can you combine resources and activities, ... These are just a few of ...
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- ScriptPro, of Mission, ... Powers Lake, Wisconsin , announce that they ... co-marketing agreement allowing ScriptPro to bring TCGRx adherence ... the United States . ScriptPro is a ... systems to retail and ambulatory pharmacies. TCGRx distributes ...
(Date:7/25/2014)... Trinidad and Tobago , July 25, 2014 ... the Trinidad & Tobago Ministry of Health approved ... therapy that significantly increases the cure rate from ... infected with the genotype 1 virus. Telaprevir is ... the trade brand INCIVO®. Photo - ...
Breaking Medicine Technology:Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3The Hepatitis C virus is the main cause of liver transplant in the world 2The Hepatitis C virus is the main cause of liver transplant in the world 3
... Systech International, innovator of Packaging Execution Systems ... leading supplier of end-of-line packaging systems, today announced ... global serialization requirements at Pack Expo 2010 in ... opportunity to examine first hand the actual system ...
... Oct. 27 Alan L. Rubino, former Hoffmann-La Roche ... companies, and Timothy G. Rothwell, former Chairman, CEO, and ... American Therapeutics, Inc.   Mr. Rubino will ... function as the company,s Chairman.  The company,s key emphasis ...
Cached Medicine Technology:Systech and Pester Pac Automation Exhibit Integrated Serialization Solution at Pack Expo 2010 2Veteran Pharmaceutical Executives Form New American Therapeutics, Inc. 2
(Date:7/26/2014)... (PRWEB) July 26, 2014 The number ... state and federal litigations since the 2012 recall of ... 3,700 filings, Bernstein Liebhard LLP reports. According to a ... 2,064 cases have been filed in the New Jersey’s ... Stem and the ABG II Modular Hip Stem Litigation, ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 As reported ... trends are changing based on 3 factors: smaller spaces, ... several top bathroom trend of 2014 lists, including ... increased popularity. Amerec , a leading manufacturer of ... steam bathing largely due to smaller spaces and an ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 ... recently updated by Vkool.com, this is a ... safe methods for treating all types of ...     Tinnitus due to Ménière's ... ,     Nerve pathway tinnitus , ...
(Date:7/26/2014)... TX (PRWEB) July 26, 2014 ... or encephalomyelitis disseminata, is an inflammatory disease in ... the brain and spinal cord are damaged. This ... nervous system to communicate, resulting in a wide ... and sometimes psychiatric problems. Multiple sclerosis takes several ...
(Date:7/26/2014)... July 26, 2014 Another DePuy Pinnacle hip ... Inc., has been filed by Wright & Schulte LLC. ... on behalf of an Erie County, Ohio man who alleges ... hip and groin since receiving his Pinnacle Hip implant in ... will be forced to undergo a complex and risky revision ...
Breaking Medicine News(10 mins):Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit Filings in State and Federal Litigations Continue to Rise, Bernstein Liebhard LLP Reports 3Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 2Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 3Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 4Health News:DePuy Pinnacle Hip Lawsuit Filed By Wright & Schulte LLC On Behalf of Recipient Who Faces Surgery To Replace Artificial Hip Implant 5
... , , BEDFORD, Ohio, July ... announced FDA approval to begin shipping Ceftriaxone for Injection USP. ... Roche. Ceftriaxone is a semisynthetic, broad-spectrum antibiotic used to treat ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20070809/CLTH157LOGO ...
... can greatly influence rotavirus, spread, CDC says , THURSDAY, ... infection, a major cause of infant illness in the ... understanding of when and where infections are likely to ... new research suggests. , A team including scientists from ...
... OAKLAND, Calif., July 16 Arcadian Health announced today that Robert ... the BMO Capital Markets sponsored 9th Annual Focus on Healthcare Conference ... Broadway Hotel. Arcadian is a leading provider of Medicare Advantage health ... and other provider groups. , , ...
... , The hospital is the highest-rated ... , , CHICAGO, July 16 Northwestern ... it the highest ranked in Illinois -- as part of U.S. News & ... authoritative and influential guide evaluated 4,861 medical centers nationwide and 174 were chosen ...
... July 16 The Lewin Group today released ... claims pose in Medicaid managed care. The authors of the report recommend ... used in the Medicare Advantage managed care program. , ... Out-of-Network Payment Stu d y, " was commissioned by ...
... , , , ... AZN ) announced today that it will provide free medication ... under one of the company,s prescription savings programs. , ... for healthcare facilities provides medicines free of charge to community ...
Cached Medicine News:Health News:Bedford Laboratories(TM) to Begin Shipping Ceftriaxone for Injection USP 2Health News:New Insights Could Help Shield Babies From Diarrhea Bug 2Health News:Arcadian Chairman and Chief Executive Officer, Robert Fahlman, to Present at Focus on Healthcare Conference in New York City 2Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 2Health News:Northwestern Memorial Among America's Best Hospitals in 11 Clinical Specialties According to U.S. News' 2009 Rankings 3Health News:New Lewin Report Shows Need for National Medicaid Out-of-Network Claims Policy 2Health News:AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 2Health News:AstraZeneca Partners With Primary Health Care to Help Iowa Uninsured 3
... Blind Performance Specimens are intended for ... handling and transportation guidelines, including chain ... Testing Programs regulated by the Substance ... (SAMHSA), Health and Human Services Department ...
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
Seroconversion and Antigen Panel Chart...
... Amplichek CT/GC Controls are ... the precision of test procedures ... Neisseria gonorrhoeae. Since they are ... used with either urine or ...
Medicine Products: